Charles Kellner to Drug Resistance
This is a "connection" page, showing publications Charles Kellner has written about Drug Resistance.
Connection Strength
1.206
-
Electroconvulsive therapy for bipolar disorder: evidence supporting what clinicians have long known. J Clin Psychiatry. 2015 Sep; 76(9):e1151-2.
Score: 0.480
-
Antidepressant medication treatment failure does not predict lower remission with ECT for major depressive disorder: a report from the consortium for research in electroconvulsive therapy. J Clin Psychiatry. 2007 Nov; 68(11):1701-6.
Score: 0.279
-
Electroconvulsive therapy (ECT) in schizophrenia: a review of recent literature. Curr Opin Psychiatry. 2018 05; 31(3):213-222.
Score: 0.144
-
Treatment-resistant postictal agitation after electroconvulsive therapy (ECT) controlled with dexmedetomidine. J ECT. 2013 Jun; 29(2):e18.
Score: 0.103
-
Electroconvulsive therapy in the treatment of intractable status epilepticus. Epilepsy Behav. 2009 Sep; 16(1):189-90; author reply 191.
Score: 0.079
-
Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE). J Clin Psychiatry. 2009 Feb; 70(2):232-7.
Score: 0.076
-
The role of ECT in refractory depression. Convuls Ther. 1995 Jun; 11(2):77-9.
Score: 0.029
-
Patterns of psychotropic medication use among patients with severe depression referred for electroconvulsive therapy: data from the Consortium for Research on Electroconvulsive Therapy. J ECT. 2006 Jun; 22(2):116-23.
Score: 0.016